Q10 co-enzyme effect on fetus implantatio
Phase 2
- Conditions
- Infertility.Female infertility
- Registration Number
- IRCT2015102724746N1
- Lead Sponsor
- Women's Reproductive Health Research Center,Vice chancellor for research, Tabriz University of Medic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 128
Inclusion Criteria
Inclusion criteria; women with ages between 20 and 42 years who have a high number of embryos transferred are fresh.(The maximum number of embryos transferred in the order of 2 to 3 cycles of ovulation induction (Fresh Embryo)). Exclusion criteria; associated with individual factors such as women over 42 years; the number of embryos down; diseases such as patients with gastrointestinal disorders; patients with liver disorders; gynecological factors like endometriosis; genital anomalies such as disorders of the fallopian tube; uterine anatomic abnormalities.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Embryo Quality. Timepoint: monthly after drug Prescription. Method of measurement: evaluation of pregnancy with B-HCG test at the end of drug use.;Embryo. Timepoint: monthly after drug Prescription. Method of measurement: evaluation of pregnancy with B-HCG test at the end of drug use.;Ovule. Timepoint: monthly after drug Prescription. Method of measurement: evaluation of pregnancy with B-HCG test at the end of drug use.
- Secondary Outcome Measures
Name Time Method Pregnancy ratio. Timepoint: monthly. Method of measurement: pregnancy lab test (B-HCG).